Codebreaker Bioscience digitizes microbiome “dark matter” through sequencing, microbiology and AI to develop novel biological assets. We seek European partners, investors and Eureka collaborators for microbiome innovation in food, pharma and biotech.
Codebreaker Bioscience is a biotechnology company focused on unlocking the “dark matter” of the microbiome to develop novel biological assets for the food, pharmaceutical and biotechnology industries. By integrating DNA sequencing, microbiology, metagenomics, bioinformatics and artificial intelligence, the company transforms complex microbial data into commercially relevant solutions with strong potential for international collaborative R&D. Codebreaker is particularly interested in building Eureka-type partnerships around the development of its NGS-MBM™ Development Pipeline, a platform designed to accelerate the discovery and validation of Microbiome Modulators, including probiotics and other microbiome-based products. The objective is to use large-scale metagenomic data to shorten development cycles and enable the design of high-value biological solutions for livestock, aquaculture and environmental applications such as biorremediation. For Eureka collaboration, Codebreaker is looking for companies, research and technology organisations, laboratories and industrial partners interested in co-developing new products, validating applications in relevant operational settings, scaling technological capabilities, and preparing innovative solutions for international markets. The company is also interested in partners that can support access to Europe, pilot implementation, field validation, regulatory pathways, manufacturing, and commercial deployment. Codebreaker can contribute strong capabilities to international consortia, including microorganism sequencing services, metagenomics and microbiome analysis, advanced bioinformatics pipelines, genome assembly, MAG reconstruction, taxonomic assignment, genomic annotation, and productive score generation. These capabilities can support collaborative projects aimed at developing new microbiome-based products and translating scientific discovery into market-oriented innovation. At the Global Innovation Summit, Codebreaker seeks to connect with partners that share an interest in industry-driven, high-impact collaborative R&D projects under the Eureka framework, particularly in areas related to sustainable food production, animal health, biotechnology, and environmental innovation. The company is open to exploring joint project ideas that combine complementary scientific, technological and industrial capacities to create scalable solutions with international potential.
Codebreaker Bioscience is a biotechnology company focused on transforming microbiome data into high-value biological assets for the food, pharmaceutical, and biotechnology industries. Operating at the intersection of DNA sequencing, microbiology, and artificial intelligence, the company helps unlock the “dark matter” of the microbiome to accelerate the development of novel biotechnology applications with productive and environmental impact.